Insulin Degludec, a New Generation Ultra-Long Acting Insulin, Used Once Daily or 3-Times Weekly in People with Type 2 Diabetes: Comparison to Insulin Glargine

被引：0
|
作者：
Zinman, Bernard
Fulcher, Greg
Rao, Paturi V.
Thomas, Nihal
Endahl, Lars
Johansen, Thue
Lewin, Andrew
Rosenstock, Julio
Pinget, Michel
Mathieu, Chantal
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A11 / A11
页数：1
相关论文
共 50 条
  • [1] Insulin degludec, a new generation ultra-long acting insulin, used once daily or 3-times weekly in people with type 2 diabetes: comparison to insulin glargine
    Mathieu, C.
    Fulcher, G.
    Rao, P. V.
    Thomas, N.
    Endahl, L.
    Johansen, T.
    Lewin, A. J.
    Rosenstock, J.
    Pinget, M.
    Zinman, B.
    DIABETOLOGIA, 2010, 53 : S8 - S8
  • [2] Two phase 3 trials of 3-times weekly insulin degludec versus once-daily insulin glargine in insulin-naive people with type 2 diabetes
    DeVries, J. H.
    Ratner, R. E.
    Bode, B. W.
    Russell-Jones, D. L.
    Begtrup, K.
    Johansen, T.
    Zinman, B.
    DIABETOLOGIA, 2012, 55 : S21 - S22
  • [3] Insulin Degludec, a New Generation Ultra-Long Acting Insulin, in a Mealtime plus Basal Regimen in People with Type 1 Diabetes:Comparison to Insulin Glargine
    Meneghini, Luigi F.
    Home, Philip D.
    Wendisch, Ulrich
    Ratner, Robert E.
    Endahl, Lars A.
    Johansen, Thue
    Lyby, Karsten
    Jendle, Johan H.
    Roberts, Anthony P.
    Devries, J. Hans
    Birkeland, Kare I.
    DIABETES, 2010, 59 : A152 - A152
  • [4] Once-daily use of a new generation ultra-long acting basal insulin with a bolus boost in insulin-naive people with type 2 diabetes: comparison with insulin glargine
    Cuddihy, R.
    Tack, C. J.
    Heise, T.
    Davidson, J.
    Gouet, D.
    Liebl, A.
    Romero, E.
    Mersebach, H.
    Dykiel, P.
    Jorde, R.
    DIABETOLOGIA, 2010, 53
  • [5] Degludec insulin, insuline ultra long of new generation, used once a day or 3 times per week in patients with type 2 diabetes: comparison with insulin Glargine
    Raccah, D.
    Penfornis, A.
    Huet, D.
    Valensi, P.
    Zinman, B.
    Fulcher, G.
    Rao, P.
    Thomas, N.
    Endhal, L.
    Johansen, T.
    Lewin, A.
    Rosenstock, J.
    Mathieu, C.
    Pinget, M.
    DIABETES & METABOLISM, 2011, 37 : A5 - A5
  • [6] Once-Daily Use of a New Generation Ultra-Long Acting Basal Insulin with a Bolus Boost in Insulin-Naive Subjects with Type 2 Diabetes: Comparison with Insulin Glargine
    Heise, Tim
    Tack, Cees
    Cuddihy, Bob Micheal
    Davidson, Jaime
    Gouet, Didier
    Liebl, Andreas
    Bobillo, Enrique Romero
    Mersebach, Henriette
    Dykiel, Patrik
    Jorde, Rolfe
    DIABETES, 2010, 59 : A9 - A10
  • [7] Insulin deglucec, a new generation ultra-long acting insulin, in a mealtime plus basal regimen in people with type 1 diabetes: comparison to insulin glargine
    Meneghini, L.
    Home, E.
    DeVries, J. H.
    Jendle, J.
    Endahl, L.
    Lyby, K.
    Johansen, T.
    Roberts, A.
    Ratner, R.
    Wendisch, U.
    Birkeland, K. I.
    DIABETOLOGIA, 2010, 53
  • [8] New ultra-long acting basal insulin: Insulin degludec
    Simo, Rafael
    AVANCES EN DIABETOLOGIA, 2013, 29 (01): : 4 - 11
  • [9] Insulin Degludec in Type 1 Diabetes A randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine
    Birkeland, Kare I.
    Home, Philip D.
    Wendisch, Ulrich
    Ratner, Robert E.
    Johansen, Thue
    Endahl, Lars A.
    Lyby, Karsten
    Jendle, Johan H.
    Roberts, Anthony P.
    DeVries, J. Hans
    Meneghini, Luigi F.
    DIABETES CARE, 2011, 34 (03) : 661 - 665
  • [10] IDegAsp, a soluble insulin combination of ultra-long-acting insulin degludec and insulin aspart, used once daily in basal-bolus treatment with insulin aspart in type 1 diabetes
    Hirsch, I.
    Franek, E.
    Courreges, J. P.
    Mersebach, H.
    Dykiel, P.
    Bode, B. W.
    DIABETOLOGIA, 2011, 54 : S427 - S427
12345